Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17398133rdf:typepubmed:Citationlld:pubmed
pubmed-article:17398133lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:17398133lifeskim:mentionsumls-concept:C0678209lld:lifeskim
pubmed-article:17398133lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:17398133lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:17398133lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:17398133lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:17398133pubmed:issue6lld:pubmed
pubmed-article:17398133pubmed:dateCreated2007-5-4lld:pubmed
pubmed-article:17398133pubmed:abstractTextMalaria vaccine development has so far been largely focused on antigens involved in parasite invasion pathways rather than on antigens associated with severe disease and naturally acquired immunity. Individuals repeatedly exposed to Plasmodium falciparum will eventually become immune to severe disease. Parasite-derived antigens expressed on the infected red blood cell (iRBC) surface are the main targets of protective immunity and can be explored as a rational alternative in development of an anti-malaria vaccine.lld:pubmed
pubmed-article:17398133pubmed:languageenglld:pubmed
pubmed-article:17398133pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17398133pubmed:citationSubsetIMlld:pubmed
pubmed-article:17398133pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17398133pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17398133pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17398133pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17398133pubmed:statusMEDLINElld:pubmed
pubmed-article:17398133pubmed:monthMaylld:pubmed
pubmed-article:17398133pubmed:issn1286-4579lld:pubmed
pubmed-article:17398133pubmed:authorpubmed-author:ChenQijunQlld:pubmed
pubmed-article:17398133pubmed:issnTypePrintlld:pubmed
pubmed-article:17398133pubmed:volume9lld:pubmed
pubmed-article:17398133pubmed:ownerNLMlld:pubmed
pubmed-article:17398133pubmed:authorsCompleteYlld:pubmed
pubmed-article:17398133pubmed:pagination777-83lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:meshHeadingpubmed-meshheading:17398133...lld:pubmed
pubmed-article:17398133pubmed:year2007lld:pubmed
pubmed-article:17398133pubmed:articleTitleThe naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine.lld:pubmed
pubmed-article:17398133pubmed:affiliationDepartment of Parasitology, Mycology and Environmental Microbiology, Swedish Institute for Infectious Disease Control, Sweden. qijun.chen@smi.ki.selld:pubmed
pubmed-article:17398133pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17398133pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17398133pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17398133lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17398133lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17398133lld:pubmed